Aghil Sharifzadeh | Immunology and Microbiology | Best Research Article Award

Dr. Aghil Sharifzadeh | Immunology and Microbiology | Best Research Article Award

Associate Professor, Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Iran.

Dr. Aghil Sharifzadeh is an Associate Professor in the Department of Microbiology and Immunology at the Faculty of Veterinary Medicine, University of Tehran. His research primarily focuses on medical mycology, with a particular interest in dermatophytes and Candida species. Dr. Sharifzadeh has contributed significantly to understanding the antifungal susceptibility patterns and virulence factors of various fungal pathogens. His work includes studies on the antifungal susceptibility and enzymatic activities of dermatophyte species isolated from clinical specimens in Iran, as well as evaluations of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel genital tract. Through his research, Dr. Sharifzadeh aims to enhance the diagnosis and treatment of fungal infections in both humans and animals. His dedication to the field is evident in his numerous publications and ongoing research projects, which continue to contribute to the advancement of medical mycology.

Professional Profile

Education

Dr. Aghil Sharifzadeh has pursued advanced studies in veterinary medicine and microbiology, culminating in his current role as an Associate Professor at the University of Tehran. His academic journey has equipped him with a robust foundation in medical mycology, enabling him to conduct in-depth research on fungal pathogens affecting both humans and animals. Through his education, Dr. Sharifzadeh has developed expertise in various microbiological techniques and methodologies, which he applies in his research to investigate the characteristics and behaviors of different fungal species. His educational background has been instrumental in shaping his research interests and guiding his contributions to the field of medical mycology.

Professional Experience

Dr. Aghil Sharifzadeh serves as an Associate Professor in the Department of Microbiology and Immunology at the Faculty of Veterinary Medicine, University of Tehran. In this role, he engages in teaching, research, and mentorship, contributing to the academic development of students and the advancement of scientific knowledge in medical mycology. His professional experience includes conducting research on the antifungal susceptibility and virulence factors of various fungal pathogens, with a focus on dermatophytes and Candida species. Dr. Sharifzadeh’s work extends to studying fungal infections in animals, such as green iguanas, highlighting his commitment to understanding and addressing fungal diseases across different species. His expertise and contributions have established him as a respected figure in the field of medical mycology.

Research Interests

Dr. Aghil Sharifzadeh’s research interests lie in the field of medical mycology, with a particular focus on the antifungal susceptibility and virulence factors of dermatophytes and Candida species. He investigates the enzymatic activities of these fungal pathogens, such as keratinase, elastase, lipase, and DNase, to understand their roles in infection and pathogenicity. Dr. Sharifzadeh also explores the presence and impact of fungal agents in various animal species, including studies on mixed infections in green iguanas. His research aims to enhance the diagnosis, treatment, and prevention of fungal infections in both human and veterinary medicine. Through his work, Dr. Sharifzadeh contributes to the broader understanding of fungal diseases and their management.

Research Skills

Dr. Aghil Sharifzadeh possesses a comprehensive set of research skills in medical mycology. He is proficient in conducting antifungal susceptibility testing and analyzing the enzymatic activities of fungal pathogens. His expertise includes isolating and identifying various fungal species from clinical specimens, as well as evaluating their virulence factors. Dr. Sharifzadeh is skilled in designing and implementing research studies that investigate the characteristics and behaviors of dermatophytes and Candida species. His methodological approach combines laboratory techniques with clinical insights, enabling him to produce research that is both scientifically rigorous and clinically relevant. These skills have been instrumental in advancing knowledge in the field of medical mycology.

Awards and Honors

Dr. Aghil Sharifzadeh’s contributions to medical mycology have been recognized through various awards and honors. His research has garnered citations and acknowledgment within the scientific community, reflecting the impact and significance of his work. Dr. Sharifzadeh’s dedication to advancing the understanding of fungal pathogens and improving treatment strategies has earned him a respected position among his peers. His achievements underscore his commitment to excellence in research and his role in shaping the field of medical mycology.

Conclusion

Dr. Aghil Sharifzadeh stands as a prominent figure in the field of medical mycology, with a career dedicated to exploring the complexities of fungal pathogens and their impact on health. His extensive research on the antifungal susceptibility and virulence factors of dermatophytes and Candida species has contributed significantly to the scientific community’s understanding of these organisms. Through his role as an Associate Professor at the University of Tehran, Dr. Sharifzadeh continues to educate and mentor the next generation of scientists, fostering a culture of inquiry and innovation. His work not only advances scientific knowledge but also has practical implications for the diagnosis and treatment of fungal infections in both humans and animals. Dr. Sharifzadeh’s ongoing commitment to research excellence ensures his continued influence in the field of medical mycology.

Publications Top Notes

  1. Title: Raisin Production by Convective–Microwave Dryer and Optimization of Ochratoxin A Content, Physicochemical, Sensory Characteristics, and Fungal Load of Raisin
    Authors: Majid Behfar, Ali Heshmati, Aghil Sharifzadeh, Maryam Taghdir, Sepideh Abbaszadeh
    Journal: Food Science and Nutrition
    Year: 2025

  2. Title: Impact of oleuropein on Candida albicans and Staphylococcus aureus adhesion and its mediated toxicity in Zebrafish (Danio rerio) embryos
    Authors: Samira Karzani, Aghil Sharifzadeh, Bahar Nayeri-Fasaei, Aram Sharifi, Ali Pourshaban Shahrestani
    Journal: Iranian Journal of Microbiology
    Year: 2025

  3. Title: Evaluation of antifungal and apoptotic effects of linalool, citral, and carvacrol separately and in combination with nystatin against clinical isolates of Pichia kudriavzevii
    Authors: Aghil Sharifzadeh, Bahar Nayeri-Fasaei, Sepideh Asadi, Mahdi Houshmandzad, Mohammad Hosein Ghaffari
    Journal: BMC Microbiology
    Year: 2024
    Citations: 2

  4. Title: Antimicrobial and anti-biofilm properties of oleuropein against Escherichia coli and fluconazole-resistant isolates of Candida albicans and Candida glabrata
    Authors: Mohammad Ali Esfandiary, Ali Reza Khosravi, Sepideh Asadi, Jalal Hassan, Aghil Sharifzadeh
    Journal: BMC Microbiology
    Year: 2024
    Citations: 2

  5. Title: A Report of Aflatoxicosis in Hand-fed Ewe Lambs Exhibiting Icterus After Hepatic Failure and Hemoglobinuria
    Authors: Hossein Aminianfar, Nazanin Samiee, Aghil Sharifzadeh, Seyedeh Fatemeh Safavi, Moahammadreza Mokhtari Hooyeh
    Journal: Iranian Journal of Veterinary Medicine
    Year: 2024

 

De-Wei Lai | Microbiology | Best Scholar Award

Prof. Dr. De-Wei Lai | Microbiology | Best Scholar Award

Associate Researcher at Taichung Veterans General Hospital, Taiwan

Dr. De-Wei Lai is an accomplished Associate Researcher at the Department of Medical Research, Taichung Veterans General Hospital, Taiwan. With a strong foundation in applied chemistry and immunology, he has dedicated his career to unraveling the complexities of regulatory T cells in diverse pathological conditions. Dr. Lai’s research spans autoimmunity, regenerative medicine, and the tumor microenvironment, with a focus on innovative immunotherapeutic strategies. His expertise integrates modern molecular techniques with natural extracts and traditional Chinese medicine, aiming to develop novel diagnostic and therapeutic solutions. With over 19 SCI/SCIE-indexed publications, 27 editorial appointments, and 16 awards, Dr. Lai has established himself as a leading voice in immunological research. His work, characterized by precision and translational potential, continues to shape the future of immunotherapy.

Professional Profile

Education

Dr. De-Wei Lai completed his undergraduate studies in Applied Chemistry at National Pingtung University, where he developed a deep interest in cellular metabolism and biochemical signaling pathways. He later pursued a Ph.D. in Immunology, focusing on the molecular mechanisms underlying diabetic retinopathy, which culminated in a groundbreaking publication in Circulation Research. His academic journey is marked by excellence in understanding complex immunological pathways and leveraging this knowledge for practical medical applications.

Professional Experience

Dr. Lai began his research career in 2019 at Chang Bing Show Chwan Memorial Hospital, where he studied the isolation, cultivation, and functional analysis of regulatory T cells (Tregs). His work laid the foundation for significant advancements in immunotherapy. In 2024, he joined Taichung Veterans General Hospital, where he expanded his focus to include molecular mechanisms of Tregs in autoimmune diseases, regenerative medicine, and tumor microenvironments. Throughout his career, Dr. Lai has consistently contributed to high-impact research, addressing critical gaps in clinical immunology and advancing innovative therapeutic strategies.

Research Interests

Dr. Lai’s research interests lie at the intersection of immunotherapy, molecular biology, and regenerative medicine. His laboratory explores the molecular mechanisms of regulatory T cells in autoimmune diseases, age-related degenerative conditions, and cancer. Recently, Dr. Lai has extended his work to study the potential of natural extracts, traditional Chinese medicine, and metal-organic nanoparticles as modulators of the immune system. By integrating experimental models with clinical big data, his research aims to develop novel diagnostic tools and immunotherapeutic strategies that address pressing medical challenges.

Research Skills

Dr. Lai possesses a robust skill set in immunological research and molecular biology. His expertise includes regulatory T cell isolation and expansion, animal model development for autoimmune diseases, and the study of tumor microenvironments. He is proficient in advanced techniques such as flow cytometry, immunohistochemistry, and molecular signaling analysis. His interdisciplinary approach also incorporates the evaluation of natural compounds and nanoparticles for therapeutic applications. With strong analytical skills and an eye for innovation, Dr. Lai excels in bridging basic research with translational medicine.

Awards and Honors

Dr. Lai’s contributions to immunological research have been widely recognized. He has received 16 awards and recognitions, highlighting his impact in both academic and clinical settings. These honors reflect his groundbreaking discoveries in T cell biology, innovative therapeutic approaches, and commitment to advancing immunotherapy. His editorial appointments in 27 journals and conferences further underscore his standing in the scientific community as a trusted authority in immunological research. Dr. Lai’s dedication to addressing clinical challenges continues to earn him accolades and inspire future research efforts.

Conclusion

Dr. De-Wei Lai is an excellent candidate for the Best Scholar Award due to his exceptional research achievements, dedication to addressing clinical challenges, and innovative approach to immunotherapy. While he excels in academic publication and editorial roles, areas like project leadership, patents, and international collaborations offer room for growth. Overall, his contributions to immunology and translational medicine make him a strong contender for this recognition.

Publications Top Notes

  • Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via calpain‐mediated C/EBP β and NF κ B cleavage
    • Authors: SM Wu, WY Lin, CC Shen, HC Pan, W Keh‐Bin, YC Chen, YJ Jan, DW Lai, …
    • Journal: Journal of Pineal Research, 60 (2), 142-154
    • Year: 2016
    • Citations: 98
  • Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress, and inhibiting epithelial-to-mesenchymal transition
    • Authors: SH Liu, WJ Lee, DW Lai, SM Wu, CY Liu, HR Tien, CS Chiu, YC Peng, …
    • Journal: Molecular Oncology, 9 (4), 834-849
    • Year: 2015
    • Citations: 64
  • Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model
    • Authors: HC Pan, DW Lai, KH Lan, CC Shen, SM Wu, CS Chiu, KB Wang, …
    • Journal: Carcinogenesis, 34 (11), 2568-2579
    • Year: 2013
    • Citations: 45
  • Aryl hydrocarbon receptor deficiency attenuates oxidative stress-related mesangial cell activation and macrophage infiltration and extracellular matrix accumulation in diabetic nephropathy
    • Authors: WJ Lee, SH Liu, CK Chiang, SY Lin, KW Liang, CH Chen, HR Tien, …
    • Journal: Antioxidants & Redox Signaling, 24 (4), 217-231
    • Year: 2016
    • Citations: 44
  • The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination
    • Authors: DW Lai, SH Liu, AI Karlsson, WJ Lee, KB Wang, YC Chen, CC Shen, …
    • Journal: Oncotarget, 5 (17), 7788
    • Year: 2014
    • Citations: 43
  • Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways
    • Authors: CS Chiu, CH Tsai, MS Hsieh, SC Tsai, YJ Jan, WY Lin, DW Lai, SM Wu, …
    • Journal: Cancer Letters, 442, 113-125
    • Year: 2019
    • Citations: 42
  • TPL2 (therapeutic targeting tumor progression locus-2)/ATF4 (activating transcription factor-4)/SDF1α (chemokine stromal cell-derived factor-α) axis suppresses diabetic retinopathy
    • Authors: DW Lai, KH Lin, WHH Sheu, MR Lee, CY Chen, WJ Lee, YW Hung, …
    • Journal: Circulation Research, 121 (6), e37-e52
    • Year: 2017
    • Citations: 37
  • Attenuation of in vitro and in vivo melanin synthesis using a Chinese herbal medicine through the inhibition of tyrosinase activity
    • Authors: SC Liu, ML Sheu, YC Tsai, YC Lin, CW Chang, DW Lai
    • Journal: Phytomedicine, 95, 153876
    • Year: 2022
    • Citations: 22
  • Melatonin protects retinal integrity through mediated immune homeostasis in the sodium iodate-induced mouse model of age-related macular degeneration
    • Authors: LC Ku, ML Sheu, HH Cheng, CY Lee, YC Tsai, CY Tsai, KH Lin, LC Lai, …
    • Journal: Biomedicine & Pharmacotherapy, 161, 114476
    • Year: 2023
    • Citations: 10
  • AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression
    • Authors: HH Cheng, L Hung‐Ke, ML Sheu, CY Lee, YC Tsai, DW Lai
    • Journal: Immunology, 168 (4), 654-670
    • Year: 2023
    • Citations: 8